BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16510958)

  • 1. Margins for treatment planning of proton therapy.
    Thomas SJ
    Phys Med Biol; 2006 Mar; 51(6):1491-501. PubMed ID: 16510958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of spatial dose gradients and probability density function to evaluate the effect of internal organ motion for prostate IMRT treatment planning.
    Jiang R; Barnett RB; Chow JC; Chen JZ
    Phys Med Biol; 2007 Mar; 52(5):1469-84. PubMed ID: 17301465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric consequences of intrafraction prostate motion.
    Li HS; Chetty IJ; Enke CA; Foster RD; Willoughby TR; Kupellian PA; Solberg TD
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):801-12. PubMed ID: 18234439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of MLC leaf width and PTV margin on the treatment planning of intensity-modulated stereotactic radiosurgery (IMSRS) or radiotherapy (IMSRT).
    Chang J; Yenice KM; Jiang K; Hunt M; Narayana A
    Med Dosim; 2009; 34(2):110-6. PubMed ID: 19410139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients.
    Kassim I; Dirkx ML; Heijmen BJ
    Radiother Oncol; 2009 Jul; 92(1):62-7. PubMed ID: 19278745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of interfractional set-up errors and intrafractional organ motions during IMRT for head and neck tumors to define an appropriate planning target volume (PTV)- and planning organs at risk volume (PRV)-margins.
    Suzuki M; Nishimura Y; Nakamatsu K; Okumura M; Hashiba H; Koike R; Kanamori S; Shibata T
    Radiother Oncol; 2006 Mar; 78(3):283-90. PubMed ID: 16564594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of changing technique, dose, and PTV margin on therapeutic ratio during prostate radiotherapy.
    Huang SH; Catton C; Jezioranski J; Bayley A; Rose S; Rosewall T
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1057-64. PubMed ID: 18339487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convolution method and CTV-to-PTV margins for finite fractions and small systematic errors.
    Gordon JJ; Siebers JV
    Phys Med Biol; 2007 Apr; 52(7):1967-90. PubMed ID: 17374922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
    O'Neill L; Armstrong J; Buckney S; Assiri M; Cannon M; Holmberg O
    Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations of the planning organ at risk volume (PRV) concept.
    Stroom JC; Heijmen BJ
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):279-86. PubMed ID: 16904527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-volume population histogram: a new tool for evaluating plans whilst considering geometrical uncertainties.
    Nguyen TB; Hoole AC; Burnet NG; Thomas SJ
    Phys Med Biol; 2009 Feb; 54(4):935-47. PubMed ID: 19147901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postprostatectomy target-normal structure overlap volume differences using computed tomography and radioimmunoscintigraphy images for radiotherapy treatment planning.
    Su A; Blend MJ; Spelbring D; Hamilton RJ; Jani AB
    Clin Nucl Med; 2006 Mar; 31(3):139-44. PubMed ID: 16495731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internal fiducial markers can assist dose escalation in treatment of prostate cancer: result of organ motion simulations.
    Zhang M; Moiseenko V; Liu M; Craig T
    Phys Med Biol; 2006 Jan; 51(2):269-85. PubMed ID: 16394338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of dosimetric margins in prostate IMRT treatment plans.
    Gordon JJ; Siebers JV
    Med Phys; 2008 Feb; 35(2):569-75. PubMed ID: 18383678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume.
    Admiraal MA; Schuring D; Hurkmans CW
    Radiother Oncol; 2008 Jan; 86(1):55-60. PubMed ID: 18082905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimated limits of IMRT dose escalation using varied planning target volume margins.
    Goulet CC; Herman MG; Hillman DW; Davis BJ
    Phys Med Biol; 2008 Jul; 53(14):3777-88. PubMed ID: 18574311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes.
    Hsu A; Pawlicki T; Luxton G; Hara W; King CR
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):898-902. PubMed ID: 17459610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it necessary to plan with safety margins for actively scanned proton therapy?
    Albertini F; Hug EB; Lomax AJ
    Phys Med Biol; 2011 Jul; 56(14):4399-413. PubMed ID: 21709340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors.
    Palm A; Johansson KA
    Acta Oncol; 2007; 46(4):462-73. PubMed ID: 17497313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.